Is the price of IVF in China transparent? Analysis of full cycle cost composition and hidden costs

How transparent are IVF prices in China? This article analyzes the real composition and hidden costs of IVF expenses from the dimensions of differences between public and private hospitals, costs of first/second/third-generation technologies, examination and medication costs, helping patients understand the reasons for price opacity and plan their budgets reasonably.

Is the price of IVF in China transparent? Analysis of full cycle cost composition and hidden costs
Surrogacy process 2026-07-01

Title area

Real consultation scenario Reproductive doctor observation Cost transparency

▎Clinic Dialogue —— During the expert clinic yesterday afternoon, a 35-year-old middle school teacher walked into the consultation room with a stack of test reports. Her AMH level was 1.2 ng/mL, antral follicle count was 6, and there was a small cyst on her left ovary. She asked a very direct question: "Doctor, how much does IVF actually cost? Are the prices online reliable? Why do different people quote different prices even at the same hospital?"

Why is it difficult to make IVF prices transparent?

This patient's confusion is very representative. The lack of transparency in IVF prices stems from the contradiction between the non-standardized nature of medical services and individualized treatment. Unlike purchasing a standardized product, the cost of IVF treatment is determined by multiple variables:

  • Individualized medication plans: The type, dosage, and brand (domestic/imported) of ovulation induction drugs vary greatly, accounting for 30%–50% of the total cost per cycle.
  • Differences in technical pathways: The laboratory operation costs for first-generation (conventional IVF), second-generation (ICSI), and third-generation (PGT) differ, with price ranges from 30,000 to 150,000 RMB.
  • Different hospital fee structures: Public hospitals follow government-guided prices, but some items require out-of-pocket payment; private hospitals use package plans, but the coverage of packages varies significantly.
  • Objective existence of hidden costs: Pre-treatment examinations, post-treatment follow-ups, medication adjustments, embryo freezing and storage, etc., can easily generate unplanned expenses.

These factors combined mean that even at the same hospital, the final cost for patients can differ by tens of thousands of RMB. The essence of price opacity is the combined result of medical information asymmetry and uncertainty in the treatment pathway.

Easily overlooked details: Which costs are often underestimated?

In clinical consultations, most patients initially focus only on the "egg retrieval + transfer" surgery fee, but the following aspects are often underestimated or completely overlooked:

  1. Full set of examination fees for both partners: Includes hormone panel (FSH, LH, E2), AMH, thyroid function, infectious disease screening, chromosome karyotype analysis, semen analysis, etc., totaling approximately 5,000–15,000 RMB. Some tests have a validity period (e.g., infectious disease screening is valid for 6 months), and if the cycle is delayed, retesting is required.
  2. Ovulation induction medication costs: The price difference between imported drugs (e.g., Gonal-f, Pergoveris) and domestic drugs (e.g., Lishenbao) can reach 10,000–20,000 RMB per cycle. Older patients or those with diminished ovarian reserve (e.g., AMH < 1.0 ng/mL) require higher doses, increasing medication costs accordingly.
  3. Embryo freezing and storage fees: If transferable embryos are formed after egg retrieval but are not transferred in the same month or if there are surplus embryos, the freezing fee is typically 3,000–5,000 RMB per year. Some hospitals charge annually, while others charge per straw.
  4. Additional testing fees for third-generation IVF: PGT (Preimplantation Genetic Testing) is charged per embryo, approximately 3,000–8,000 RMB per embryo, usually starting with 3–5 embryos, totaling 20,000–50,000 RMB.
  5. Follow-up examinations and medication adjustments within the cycle: Multiple monitoring sessions for follicle development (ultrasound + blood tests) are required during ovulation induction, each costing about 200–500 RMB, with 8–15 sessions per cycle. If ovarian hyperstimulation or suboptimal endometrial lining occurs, additional medication or hospitalization may be needed.

▎Clinical Observation: A 38-year-old patient with AMH 0.8 ng/mL completed a third-generation IVF cycle at a public hospital, with a final cost of 146,000 RMB. Medication costs were 42,000 RMB, PGT testing fees were 35,000 RMB, and freezing fees were 8,000 RMB. These three items combined accounted for over 58% of the total cost. These items were not fully disclosed before starting treatment.

Are IVF prices in China transparent? Direct answer

Overall transparency is low, but improving. Specifically:

  • Public tertiary hospitals: Examination fees, surgery fees, and laboratory operation fees are set by the government and are relatively transparent. However, medication costs vary greatly due to brand and dosage, and some out-of-pocket items (e.g., embryo freezing, PGT) are not fully disclosed.
  • Private fertility centers: Commonly use "package plans" (e.g., "39,800 RMB for a guaranteed success"), which seem transparent, but packages usually do not include examination fees, medication price differences, embryo freezing fees, or additional costs for upgrading technology due to medical indications (e.g., conventional IVF to ICSI).
  • Industry status: As of 2025, there is no unified national platform for disclosing assisted reproduction prices in China. Some provincial medical insurance bureaus have gradually included certain IVF items in insurance coverage (e.g., Beijing, Zhejiang, Guangdong), but coverage is limited, and information opacity remains for out-of-pocket portions.

Therefore, for patients, price transparency is relative and requires proactive verification. Before starting treatment, patients should request a detailed cost breakdown from the hospital, clearly distinguishing between "items included in the package" and "potential additional charges."

Factors influencing cost: Which variables determine the final expense?

The final cost of IVF is determined by the following six core variables:

Variable Dimension Specific Factor Impact on Cost
Technology Type First-generation IVF vs Second-generation ICSI vs Third-generation PGT ±30,000 to ±100,000 RMB
Medication Plan Imported vs Domestic drugs; duration and dosage ±10,000 to ±40,000 RMB
Hospital Type Public vs Private hospital ±20,000 to ±80,000 RMB
Patient Age & Ovarian Function AMH, Antral Follicle Count, FSH level ±10,000 to ±50,000 RMB
Embryo Handling Method Freezing, PGT, Assisted hatching ±10,000 to ±60,000 RMB
Number of Cycles Single cycle vs Multiple cycles Multiplied

For example, a 32-year-old patient with tubal factor infertility (AMH 2.5 ng/mL) undergoing first-generation IVF at a public hospital would have a total cost of approximately 35,000–55,000 RMB. In contrast, a 39-year-old patient with diminished ovarian reserve (AMH 0.7 ng/mL) undergoing third-generation IVF at a private hospital could have a total cost of 120,000–180,000 RMB. The price difference mainly stems from different technical pathways and medication dosages.

Cost differences across age groups: Why does the cost increase with age?

Age is the primary physiological variable affecting IVF costs, mainly reflected in the following three aspects:

  • Increased ovulation induction medication dosage: After age 35, ovarian response to gonadotropins declines, requiring higher doses and longer treatment duration. The medication cost per cycle for patients over 40 is typically 1.8–2.5 times that of patients under 30.
  • Need for more advanced technology: The rate of embryonic aneuploidy increases significantly in older women (60%–80% for those over 40), often necessitating PGT for embryo selection, adding an extra 20,000–50,000 RMB in testing fees.
  • Cycle cancellation rate and repeated cycles: Older patients have a higher probability of cycle cancellation due to poor follicle development, empty follicles, or lack of transferable embryos. They may need 2–3 cycles to achieve a live birth, resulting in a multiplied total cost.

▎Doctor's Advice: Patients under 35 who fail their first IVF cycle still have a high probability of success in subsequent cycles. Patients over 40 are advised to fully assess ovarian reserve (AMH + antral follicle count) before starting treatment, prepare for multiple cycles, and pay attention to medical insurance coverage for older age groups.

Differences in hospital charges: Public vs Private – how to choose?

The hospital's fee structure directly determines price transparency and actual cost:

Comparison Dimension Public Tertiary Hospital Private Fertility Center
Price Transparency Itemized billing, government-guided prices, but some items require out-of-pocket payment Mainly package-based, seemingly transparent but with many hidden items
Cost Range per Cycle 35,000 – 80,000 RMB 60,000 – 180,000 RMB
Medication Choice Domestic/imported options available; doctor recommends based on patient condition Some packages restrict to imported drugs or specific brands
Additional Charge Items Embryo freezing, PGT, assisted hatching, refund for cycle cancellation Examination fees, medication price differences, technology upgrade fees, freezing fees
Suitable for Patients under 35, normal ovarian function, limited budget Older patients, complex cases, those seeking service experience

Selection Advice: Public hospitals are suitable for patients who are price-sensitive, willing to wait in line, and have relatively straightforward conditions. Private hospitals are more suitable for older patients, those needing personalized services, or those who wish to complete the cycle in a shorter time. Regardless of the choice, it is essential to obtain a complete cost estimate before starting treatment and to have a written confirmation of the list and standards for "out-of-package charges."

Doctor's perspective: Why is price transparency so difficult to achieve?

As a reproductive doctor, I would like to explain from an internal industry perspective why price transparency is hard to achieve:

  1. Unpredictability of the medical process: Each patient's ovarian response, embryo development, and endometrial receptivity are different. For example, egg retrieval surgery seems standard, but details like the number of needle punctures, follicle flushing次数, and whether ultrasound-guided puncture is needed can affect the final cost.
  2. Medication costs are influenced by multiple factors: The dosage of ovulation induction drugs depends on the patient's response to the medication, which cannot be fully predicted before treatment. The dosage of the same drug can vary more than threefold between different patients.
  3. Technical stratification in laboratory operations: Embryo culture can be "standard culture" or "time-lapse culture," and ICSI can be "conventional ICSI" or "IMSI (high-magnification microinjection)." These technological upgrades usually come with additional charges, but patients often do not understand the differences.
  4. Incomplete medical insurance coverage: As of 2025, only about 10 provinces in China have included some assisted reproduction items in medical insurance, with significant differences in reimbursement rates and scope, making out-of-pocket price information even more fragmented.

From a doctor's perspective, we hope to inform patients of the approximate cost range and potential risks before treatment, but medical uncertainty means that a "fixed price" is impossible. Transparency is not simply giving a number, but clearly and stage-by-stage informing the cost composition and possible changes.

▎Risk Reminder

IVF costs are influenced by multiple factors. Any promotion promising a "fixed price for success" should be treated with caution. Before starting treatment, be sure to confirm: ① Whether the cost list includes all examination items for both partners; ② Whether medication costs distinguish between domestic and imported drugs, and how charges are applied if usage exceeds the package limit; ③ Whether laboratory operations such as embryo freezing, PGT, and assisted hatching are billed separately; ④ The refund policy in case of cycle cancellation or interruption. It is recommended to choose a medical institution with a clear cost disclosure system and written informed consent, and to keep all payment receipts during treatment. Price transparency is not only a patient need but also an important indicator of medical quality.

Related Knowledge: AMH · FSH · LH · Antral Follicle Count · Semen Analysis · Chromosome Testing · Genetic Counseling · Hysteroscopy · Filing · Ovulation Induction · Egg Retrieval · Embryo Culture · PGT · Frozen Embryo · Transfer · Luteal Support · Reproductive Doctor · Laboratory · First-generation IVF · Second-generation IVF · Third-generation IVF

Common Queries: When to do IVF examinations · How long to prepare for IVF in advance · Price differences between first, second, and third-generation IVF · Public hospital IVF pricing standards · IVF ovulation induction medication costs · How much does IVF cost for older women · How to avoid hidden IVF costs · Detailed IVF cost list

Comments (0)

Leave a Comment